Net profit surged, thanks to the sale of one of its business units. In July the company sold its targeted-therapies unit to BTG PLC for $190M, resulting in a gain of about $182M.
Total revenue grew by 6.8% Y/Y, while gross margin was flat at 55%.
Medical-isotopes segment sales +9% Y/Y.
Sterilization-technologies sales +14%.